arrow
返回
A

Anne‐Marie C. Dingemans

Erasmus University Medical Center

71H指数
672论文数
2.1W被引数
收录论文 203
发表时间
Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer非小细胞肺癌患者使用小分子抑制剂处方的药理学考量
err2026-09-15
err0
errOAAI
errLotte M.G. Hulskotte; G.D. Marijn Veerman; Daan A.C. Lanser; Anna K.L. Reyners; Ron H.N. van Schaik; Anne-Marie C. Dingemans; Katja Taxis; Ron H.J. Mathijssen; Frank G.A. Jansman
err分享
err收藏
Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids肺神经内分泌肿瘤和类癌的深层分子谱分析
err2026-08-27
err0
errOAAI
errAlexandra Sexton-Oates; Émilie Mathian; Noah Candeli; Yuliya Lim; Catherine Voegele; Alex Di Genova; Laurane Mangé; Zhaozhi Li; Tijmen van Weert; Lipika Kalson; Tiffany M. Delhomme; Lisa M. Hillen; Ricardo Blázquez-Encinas; Abel Gonzalez-Perez; Maike L. Morrison; Eleonora Lauricella; Lise Mangiante; Lisa Bonheme; Laura Moonen; Gudrun Absenger; Janine Altmuller; Cyril Degletagne; Odd Terje Brustugun; Vincent Cahais; Giovanni Centonze; Amélie Chabrier; Cyrille Cuenin; Francesca Damiola; Vincent Thomas de Montpréville; Jean-François Deleuze; Anne-Marie C. Dingemans; Élie Fadel; Nicolas Gadot; Akram Ghantous; Paolo Graziano; Paul Hofman; Véronique Hofman; Alejandro Ibáñez-Costa; Stéphanie Lacomme; Nuria Lopez-Bigas; Marius Lund-Iversen; Massimo Milione; Lucia Anna Muscarella; Sergio Pedraza-Arevalo; Corinne Perrin; Gaetane Planchard; Helmut Popper; Luca Roz; Angelo Sparaneo; Wieneke Buikhuisen; José van den Berg; Margot Tesselaar; Jaehee Kim; Ernst Jan M. Speel; Séverine Tabone-Eglinger; Thomas Walter; Gavin M. Wright; Justo P. Castaño; Lara Chalabreysse; Liming Chen; Christophe Caux; Marco Volante; Nicolas Girard; Jean-Michel Vignaud; Esther Conde; Audrey Mansuet-Lupo; Luka Brcic; Giuseppe Pelosi; Mauro Giulio Papotti; Sylvie Lantuejoul; Jules Derks; Talya Dayton; Nicolas Alcala; Matthieu Foll; Lynnette Fernandez-Cuesta
err分享
err收藏
Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC简报:通过建立最优暴露-毒性阈值来降低NSCLC患者Lorlatinib相关不良反应
err2026-07-16
err0
errOAAI
errDaan A.C. Lanser; Lisanne N. van Merendonk; G.D.Marijn Veerman; Salomé van Beusekom; Esther Oomen-de Hoop; Peter de Bruijn; Attila Icli; Marthe S. Paats; Alwin D.R. Huitema; Ron H.N. van Schaik; Sushil Badrising; Anne-Marie C. Dingemans; Ron H.J. Mathijssen
err分享
err收藏
Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasmsSLFN11在肺小细胞癌、类癌和大细胞神经内分泌癌中的表达分析:对肺神经内分泌肿瘤的见解
err2026-07-13
err0
errOAAI
errDaniela Scattolin; Frank W.J. Heijboer; Giulia Pigato; Jules L. Derks; Ernst-Jan M. Speel; Tijmen van Weert; Daphne W. Dumoulin; Biancamaria Di Domenico; Lisa M. Hillen; Valentina Guarneri; Anne-Marie C. Dingemans; Giulia Pasello; Jan H. von der Thüsen
err分享
err收藏
Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer疑似转移性肺癌患者中游离DNA下一代测序的前瞻性临床评估
err2026-04-08
err0
errOAAI
errChristi M. J. Steendam; Ruud W. J. Meijers; Peggy Atmodimedjo; Lisette van Dijk; Cor van der Leest; Keetie C. J. van Loenhout; Susan C. van ’t Westeinde; Daphne W. Dumoulin; Wessel E. J. J. Hanselaar; Marthe S. Paats; Evert de Jonge; Ron H. N. van Schaik; Jan H. von der Thüsen; Joachim G. J. V. Aerts; Anne-Marie C. Dingemans; Hendrikus Jan Dubbink
err分享
err收藏
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancerEORTC 1417 - REACTION:一项关于依托泊苷联合顺铂/卡铂,并联合或不联合帕博利珠单抗治疗初治广泛期小细胞肺癌的II期研究
err2025-10-30
err0
PREAI
errJessica Menis; Laurent Greiller; Pierre Demontrond; Isabelle Monnet; Silvia Novello; Lorenzo Livi; Robin Young; Chantal Decroisette; Nicolas Cloarec; Gilles Robinet; Roland Schott; Jerome Fayette; Giuseppe Luigi Banna; Filippo De Marinis; Raffaele Califano; Boris Duchemann; Andrea Luciani; Ida Colantonio; Beatrice Fournier; Yassin Pretzenbacher; Caroline Caramella; Mario Silva; Thierry Berghmans; Anne-Marie Dingemans; Paolo Bironzo; Jonathan Tugwood; Cong Zhou; Steven Hill; Kieran Bradbury; Karen Morris; Elaine Kilgour; Caroline Dive; Fiona Blackhall; Benjamin Besse
err分享
err收藏
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity长期接受帕博利珠单抗单药治疗的患者中,具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局:基于Transformer的AI用于表征预后复杂性
err2025-10-16
err0
errOAAI
errAlessio Cortellini; Edoardo Garbo; Giulia La Cava; Fabrizio Citarella; Valentina Santo; Leonardo Brunetti; David J Pinato; Jarushka Naidoo; Monica Loza; Carlo Genova; Scott Gettinger; So Yeon Kim; Ritujith Jayakrishnan; Talal El Zarif; Marco Russano; Federica Pecci; Alessandro Di Federico; Michele Montrone; Dwight H Owen; Diego Signorelli; Mingjia Li; Andrea Camerini; Balazs Halmos; Bruno Vincenzi; Giulio Metro; Sai Yendamuri; Francesco Grossi; Eleni Josephides; Bartłomiej Tomasik; Raffaele Giusti; Emilio Bria; Martin Sebastian; Maximilian Rost; Fabian Acker; Lorenza Landi; Francesca Mazzoni; Alessandro Morabito; Alessandro Leonetti; Luca Cantini; Giannis Mountzios; Sukumar Kalvapudi; David O’Reilly; Eleni Karapanagiotou; Isabelle Monnet; Javier Baena; Marianna Macerelli; Margarita Majem; Aida Piedra; Diego L Cortinovis; Giuseppe Tonini; Gabriele Minuti; Laura Mezquita; Teresa Gorria; Teresa Beninato; Giuseppe Lo Russo; Arsela PrelaJ; Andrea De Giglio; Federica Biello; Frank Aboubakar Nana; Anne-Marie C. Dingemans; Joachim GJV Aerts; Roberto Ferrara; Taher Abu Hejleh; Kazuki Takada; Abdul R Naqash; Marina C Garassino; Heather A. Wakelee; Amin Nassar; Biagio Ricciuti; Paolo Soda; Camillo Maria Caruso; Valerio Guarrasi
err分享
err收藏
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group纳入临床试验的可切除III期非小细胞肺癌(NSCLC)定义:由EORTC肺癌组领导的泛欧洲多学科专家小组的临床病例回顾
err2025-10-14
err0
PREAI
errMariana Brandão; Elena Prisciandaro; Eleni Xenophontos; Alessio Mariolo; Amir H. Sadeghi; Andrea R. Filippi; Antonin Levy; Artur Bandura; Caroline Caramella; Chris Dickhoff; Constance de Margerie-Mellon; Corinne Faivre-Finn; Daniel Portik; David Sanchez-Lorente; Dirk De Ruysscher; Egbert Smit; Elisa Gobbini; Elie Fadel; Enrico Ruffini; Emanuela Olmetto; Francesco Cortiula; Idris Bahce; Ilias Houda; Isabelle Opitz; Jarushka Naidoo; John Edwards; Jordi Remon; José Carlos Benitez; Juan Carlos Trujillo; Jules Derks; Karim Amrane; Koen J. Hartemink; Konstantinos Stathopoulos; Lizza E.L. Hendriks; Manoli Iglesias; Mario Occhipinti; Matthias Guckenberger; Niccolo Giaj Levra; Nicolas Girard; Noemi Reguart; Olaf Mercier; Paolo Bironzo; Paul Hofman; René Horsleben Petersen; Riccardo De Angelis; Ronan Abgral; Safae Terrisse; Sanjay Popat; Thomas Pierret; Torsten Gerriet Blum; Umberto Ricardi; Valeria Dionisi; Thierry Berghmans; Anne-Marie C. Dingemans
err分享
err收藏
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study确定识别奥希康替尼耐药性的最佳方法;OSIRIS研究中的奥希康替尼一线治疗队列
err2025-09-28
err0
PREAI
errJ.W.T. van der Wel; S.M. Ernst; M. Jebbink; D. van den Broek; S.K. Badrising; L.C. Steinbusch; G. Ruiter; W.S.M.E. Theelen; B.A.M.H. van Veggel; J. Smit; A.M. Dingemans; M.S. Paats; H.J. Dubbink; S.M.S. Hashemi; T. Radonic; D. Cohen; A.J. van der Wekken; A. ter Elst; W. Timens; L.E. Hendriks; E.J.M. Speel; M.M.J. Disselhorst; A. Welling; F. van der Meer; L.J.W. Bosch; K. Monkhorst; M.C. Boelens; E.F. Smit; A.J. de Langen
err分享
err收藏
COMPREHENSIVE ANALYSIS OF NEUROD1, ASCL1, POU2F3 AND YAP1 EXPRESSION SIGNATURES REVEAL UNIQUE LCNEC SUBGROUPS WITH POTENTIAL THERAPEUTIC IMPLICATIONS对NEUROD1、ASCL1、POU2F3和YAP1表达特征的综合分析揭示了具有潜在治疗意义的独特LCNEC亚群。
err2025-09-01
err0
errOAAI
errFrank W.J. Heijboer; Jules L. Derks; Dana A.M. Mustafa; Nicole Rijnsburger; Bregtje C.M. Hermans; Lisa M. Hillen; Ernst-Jan M. Speel; Anne-Marie C. Dingemans; Jan H. von der Thüsen
err分享
err收藏
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC关于SLFN11作为小细胞肺癌(SCLC)新兴生物标志物的临床见解及其通路研究
err2025-08-15
err0
PREAI
errDaniela Scattolin; Frank W.J. Heijboer; Jules L. Derks; Jan H. von der Thüsen; Daphne W. Dumoulin; Ernst-Jan M. Speel; Valentina Guarneri; Giulia Pasello; Anne-Marie C. Dingemans
err分享
err收藏
Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial索托拉西布与多西他赛在经治KRAS G12C突变型晚期非小细胞肺癌中的颅内活性比较:一项全球性、III期、随机对照试验
err2025-07-29
err0
errOAAI
errAnne-Marie C. Dingemans; Konstantinos Syrigos; Lorenzo Livi; Astrid Paulus; Sang-We Kim; Yuanbin Chen; Enriqueta Felip; Frank Griesinger; Kadoaki Ohashi; Gerard Zalcman; Brett G.M. Hughes; Jens Benn Sørensen; Normand Blais; Carlos G.M. Ferreira; Colin R. Lindsay; Rafal Dziadziuszko; Patrick J. Ward; Cynthia Chinedu Obiozor; Yang Wang; Solange Peters
err分享
err收藏
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group可切除的III期非小细胞肺癌的定义:一项来自EORTC肺癌组的系统评价
err2025-07-19
err0
PREAI
errE. Xenophontos; N. Giaj Levra; V. Durieux; W.H. van Geffen; G. Grisay; C. De la Pinta Alonso; H. Arasanz; E. Prisciandaro; R. Ferrara; J. Derks; J. Von der Thusen; C. Dickhoff; M. Brandão; C. Faivre-Finn; J. Edwards; D.De Ruysscher; J. Remon; A-M.C. Dingemans; T. Berghmans
err分享
err收藏
Bringing evolutionary cancer therapy to the clinic: a systems approach将进化癌症疗法引入临床:一种系统方法
err2025-05-27
err0
errOAAI
errSoboleva, Arina; Grossmann, Irene; Dingemans, Anne-Marie C.; Rezaei, Jafar; Stankova, Katerina
err分享
err收藏
Deep Learning–Based Retinoblastoma Protein Subtyping of Pulmonary Large-Cell Neuroendocrine Carcinoma on Small Hematoxylin and Eosin–Stained Specimens基于深度学习的肺大细胞神经内分泌癌小标本苏木精和伊红染色切片Rb蛋白亚型分类
err2025-05-08
err0
errOAAI
errTeodora E. Trandafir; Frank W.J. Heijboer; Farhan Akram; Jules L. Derks; Yunlei Li; Lisa M. Hillen; Ernst-Jan M. Speel; Zsolt Megyesfalvi; Balazs Dome; Andrew P. Stubbs; Anne-Marie C. Dingemans; Jan H. von der Thüsen
err分享
err收藏
Response to Letter to Editor-in-Chief and Redefining Resectability: Bridging Perspectives in Stage III NSCLC Management对《致主编函》的回应与可切除性的重新定义:弥合III期NSCLC管理中的不同观点
err2025-05-01
err0
PREAI
errHoudaa, Ilias; Bahcea, Idris; Remonb, Jordi; Berghmansc, Thierry; Faivre-Finnd, Corinne; Dingemansf, Anne-Marie C.; Besseb, Benjamin; Hendriksg, Lizza E. L.
err分享
err收藏
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study司美格鲁肽降低阿来替尼的生物利用度:一项基于交叉药代动力学药物相互作用研究的警告说明
err2025-05-01
err0
errOAAI
errNiels Heersche; Daan A. C. Lanser; Esther Oomen-de Hoop; Attila Içli; Peter de Bruijn; Marthe S. Paats; Elisabeth F. C. van Rossum; Stijn L. W. Koolen; Ron H. N. van Schaik; Anne-Marie C. Dingemans; G. D. Marijn Veerman; Ron H. J. Mathijssen
err分享
err收藏